COURTNEY HOUDE: Open Payments
NPI 1992058689 · MEDFORD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$635 in 40 payments from 17 companies in 2025. Trend: 2023 $583 · 2024 $1,066 · 2025 $635
Food & beverage: $635
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 5 | $85 |
| Incyte Corporation | 4 | $75 |
| Kerecis Limited | 2 | $70 |
| E.R. Squibb & Sons, L.L.C. | 3 | $49 |
| Organogenesis Inc. | 2 | $49 |
| LEO Pharma Inc. | 3 | $48 |
| Lilly USA, LLC | 2 | $33 |
| Galderma Laboratories, L.P. | 2 | $33 |
| Novartis Pharmaceuticals Corporation | 2 | $32 |
| ABBVIE INC. | 2 | $30 |
Products named: CIBINQO, OPZELURA, Kerecis SurgiClose, AFFINITY, NEMLUVIO, COSENTYX, SKYRIZI, ADBRY.
Industry payments across NJ — which companies pay providers there.
